Popular search terms:
Search Results Label
26 results found-
Seqirus | Career Opportunities
Interested in career opportunities at Seqirus, a global biopharmaceutical company producing world-class influenza vaccines?
https://www.seqirus.com/careers -
Seqirus | Working For Our Team
We've built a collaborative team of the best and brightest. Interested in joining us to make a difference across the world? Learn more here.
https://www.seqirus.com/careers/see-yourself-at-seqirus -
Seqirus | Diversity & Inclusion
Seqirus aims to respect and encourage all forms of diversity, including gender, age, ethnicity, sexual orientation, cultural background and more. Learn more.
https://www.seqirus.com/careers/diversity-and-inclusion -
Seqirus | Employee Testimony
Hear from our employees about the culture, development opportunities, strong teamwork and shared purpose at Seqirus.
https://www.seqirus.com/careers/discover-our-people -
Seqirus | Employee Support
At Seqirus, we're committed to attracting and retaining world-class employees. Learn more about how we support our team.
https://www.seqirus.com/careers/how-we-care-for-you-at-seqirus -
Gyuri Endes
Our leadership team is composed of experienced professionals with deep scientific expertise and a shared commitment to public health. Meet them now.
https://www.seqirus.com/our-company/leadership/gyuri-endes -
CSL's Statement on the Prevention of Human Trafficking, Slavery and Forced Labour (Modern Slavery) 1 July 2018 to 30 June 2019
Our representative participated in and learned from updates provided by the Institute for Human Rights and Business (IHRB), "Hope for Justice", "Safer Jobs", and firms with leading efforts such as HP, Marshalls. •
https://www.seqirus.com/-/media/seqirus/pdfs/csl-statement-on-modern-slavery-2019.pdf -
Anjana Narain to Lead Seqirus Influenza Vaccines Business
CSL Limited today named Anjana Narain, a seasoned leader in vaccines and biopharmaceuticals, as Executive Vice President and General Manager of its Seqirus business, one of the world’s largest influenza vaccines providers, effective 1 August. She will replace Gordon Naylor, who announced his retirement earlier this year.
https://www.seqirus.com/news/anjana-narain-to-lead-seqirus-influenza-vaccines-business -
Stephen Marlow
Our leadership team is composed of experienced professionals with deep scientific expertise and a shared commitment to public health. Meet them now.
https://www.seqirus.com/our-company/leadership/stephen-marlow -
Ken Lim
Our leadership team is composed of experienced professionals with deep scientific expertise and a shared commitment to public health. Meet them now.
https://www.seqirus.com/our-company/leadership/ken-lim